Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesSymptomatic Response Rates to Testosterone Therapy and the Likelihood of Completing 12 Months of Therapy in Clinical Practice
The Journal of Sexual Medicine, 10/29/09
Rhoden EL et al. – Approximately two–thirds of men with TD who begin TTh will experience symptomatic benefit and will complete at least 12 months of treatment. Benefit was noted in a majority by 3 months.
Related Articles
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Relevance Score: 95%
Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 94%
Testosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09
Relevance Score: 93%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09
Relevance Score: 91%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
NIH, 11/03/09
Relevance Score: 91%
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Primary adrenal failure due to viral infection in an infant
European Journal of Pediatrics, 11/25/09
Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function
International Journal of Andrology, 11/13/09
Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09
Article Search
Sponsor